The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Truly believe there will be Public inquiry into the farce the whole testing process has been and it’ll boil down to cost, the government knew the primer design test was on the market but chose to go with cheaper knock offs, by the time they’d realised that it was to late, every other country had bought up primer designs manufacturing capacity for the near future
Whilst the impact of COVID-19 in the final quarter was a major challenge the
Company still delivered a strong end to the year. Yourgene has in place robust
systems to continue to operate efficiently and to provide customers with
world-leading molecular diagnostic solutions and services. In addition, as
announced on 25 March 2020, the Company signed a contract manufacturing
agreement with Novacyt S.A. ("Novacyt") to support the production of COVID-19
diagnostic tests developed by Primerdesign, Novacyt's molecular diagnostics
division. The contribution from this partnership has started to crystallise in
the new financial year with our first shipments now successfully completed.
Lyn Rees, Chief Executive Officer of Yourgene, commented:
"I am delighted with the performance of our business over the year, both in
terms of the organic growth and through contributions from acquisitions.
Despite the COVID-19 crisis we continue to execute on our strategy of
broadening our product mix and international reach, and we are proud to be
supporting the global manufacturing efforts for COVID-19 diagnostic tests from
our state-of-the-art facilities in Manchester. The Group remains well funded
to achieve its objectives and we are confident that our business remains
robust going into the new financial year. In our view the challenging global
situation has put into focus more than ever the need for reliable and accurate
diagnostic testing and Yourgene is well positioned to make a significant
contribution."
For those that missed it